China Market Access Strategist – Rare Diseases

Alexion Pharmaceuticals, Inc. seeks a GVAP China Strategic Access Lead based in Barcelona to guide market access and pricing initiatives for China.You will collaborate with AZ China, GVAP teams, and global partners to shape strategic access solutions for rare diseases in key markets. The role requires in-depth knowledge of RD market access ecosystems, with...

Sandoz is seeking a Global Director Market Access to steer the global market access strategy for biosimilars, ensuring competitive access and pricing across priority markets. This role focuses on launch readiness, pricing governance, and core market access materials to enable regions and countries to execute effectively.Responsibilities include defining...

Alexion, based in Barcelona, is seeking a GVAP China Strategic Access Lead to shape and implement market access and pricing strategies for China, coordinating with AZ China and global teams.¿Es usted el candidato adecuado para esta oportunidad? Asegúrese de leer la descripción completa a continuación.You will drive cross-functional programs and...

China is a key growth driver and enabler to the Alexion 2030 ambition. China’s rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to evolve. Further development of dedicated rare disease policies, funding mechanisms, and an integrated access ecosystem will be important to recognize...

Alexion seeks a GVAP China Strategic Access Lead based in Barcelona to drive market access and pricing strategies for China, collaborating with AZ China and global teams to position rare disease therapies for successful market entry.You will shape cross-functional programs, engage payers and government stakeholders, and build capability across China teams,...

China is a key growth driver and enabler to the Alexion 2030 ambition.¿Todo listo para enviar su solicitud? Asegúrese de comprender todas las responsabilidades y tareas asociadas a este puesto antes de continuar.China’s rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to...

Alexion, based in Barcelona, seeks a GVAP China Strategic Access Lead to drive innovative access solutions for rare diseases in China, collaborating with AZ China and global teams to shape market access and pricing strategies. You will build cross-functional capabilities, engage payers and government stakeholders, and navigate China’s RD landscape,...

China is a key growth driver and enabler to the Alexion 2030 ambition. China’s rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to evolve. Further development of dedicated rare disease policies, funding mechanisms, and an integrated access ecosystem will be important to recognize...

China is a key growth driver and enabler to the Alexion 2030 ambition. China’s rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to evolve. Further development of dedicated rare disease policies, funding mechanisms, and an integrated access ecosystem will be important to recognize...